These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35904175)

  • 1. Long non‑coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway.
    Sun X; Xin S; Zhang Y; Jin L; Liu X; Zhang J; Mei W; Zhang B; Ma W; Ye L
    Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35904175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA.
    Shi X; Zhang W; Nian X; Lu X; Li Y; Liu F; Wang F; He B; Zhao L; Zhu Y; Ren S; Sun Y
    Int J Cancer; 2020 Jan; 146(2):475-486. PubMed ID: 31107971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CASC11 promotes aggressiveness of prostate cancer cells through miR-145/IGF1R axis.
    Capik O; Sanli F; Kurt A; Ceylan O; Suer I; Kaya M; Ittmann M; Karatas OF
    Prostate Cancer Prostatic Dis; 2021 Sep; 24(3):891-902. PubMed ID: 33753875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
    Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
    Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
    [No Abstract]   [Full Text] [Related]  

  • 5. Long non-coding RNA LINP1 promotes the malignant progression of prostate cancer by regulating p53.
    Wu HF; Ren LG; Xiao JQ; Zhang Y; Mao XW; Zhou LF
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4467-4476. PubMed ID: 30058678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA PRKCQ-AS1 promotes CRC cell proliferation and migration via modulating miR-1287-5p/YBX1 axis.
    Cui G; Zhao H; Li L
    J Cell Biochem; 2020 Oct; 121(10):4166-4175. PubMed ID: 32619070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA CASC11 promoted gastric cancer cell proliferation, migration and invasion in vitro by regulating cell cycle pathway.
    Zhang L; Kang W; Lu X; Ma S; Dong L; Zou B
    Cell Cycle; 2018; 17(15):1886-1900. PubMed ID: 30200804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA Linc01612 represses hepatocellular carcinoma progression by regulating miR-494/ATF3/p53 axis and promoting ubiquitination of YBX1.
    Liu P; Zhong Q; Song Y; Guo D; Ma D; Chen B; Lan J; Liu Q
    Int J Biol Sci; 2022; 18(7):2932-2948. PubMed ID: 35541917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel androgen-reduced prostate-specific lncRNA, PSLNR, inhibits prostate-cancer progression in part by regulating the p53-dependent pathway.
    Wang D; Wan X; Zhang Y; Kong Z; Lu Y; Sun X; Huang Y; Ji C; Li D; Luo J; Gu W; Wang C; Li Y; Xu Y
    Prostate; 2019 Sep; 79(12):1362-1377. PubMed ID: 31269242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA PlncRNA-1 accelerates the progression of prostate cancer by regulating PTEN/Akt axis.
    Cui Z; Gao H; Yan N; Dai Y; Wang H; Wang M; Wang J; Zhang D; Sun P; Qi T; Wang Q; Kang W; Jin X
    Aging (Albany NY); 2021 Apr; 13(8):12113-12128. PubMed ID: 33848262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA CASC11 promotes the development of esophageal carcinoma by regulating KLF6.
    Chen SG; Wang CH; He RQ; Xu RY; Ji CB
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8878-8887. PubMed ID: 31696474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lncRNA CASC11 promotes cancer cell proliferation in bladder cancer through miRNA-150.
    Luo H; Xu C; Le W; Ge B; Wang T
    J Cell Biochem; 2019 Aug; 120(8):13487-13493. PubMed ID: 30916832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promotion of colorectal cancer progression by immune-related lnc-SOX9-4 via suppression of YBX1 poly-ubiquitination and degradation.
    Zhao Y; Yang S; Nie H; Zhang D; Wang T; Sun Q; Wang X; Sun Y
    Cell Signal; 2023 Nov; 111():110854. PubMed ID: 37611648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA PCA3 regulates prostate cancer through sponging miR-218-5p and modulating high mobility group box 1.
    Zhang G; He X; Ren C; Lin J; Wang Q
    J Cell Physiol; 2019 Aug; 234(8):13097-13109. PubMed ID: 30569456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of AR-regulated lncRNA TMPO-AS1 correlates with tumor progression and poor prognosis in prostate cancer.
    Huang W; Su X; Yan W; Kong Z; Wang D; Huang Y; Zhai Q; Zhang X; Wu H; Li Y; Li T; Wan X
    Prostate; 2018 Dec; 78(16):1248-1261. PubMed ID: 30105831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RP11-296E3.2 acts as an important molecular chaperone for YBX1 and promotes colorectal cancer proliferation and metastasis by activating STAT3.
    Shi Q; He Y; He S; Li J; Xia J; Chen T; Huo L; Ling Y; Liu Q; Zang W; Wang Q; Tang C; Wang X
    J Transl Med; 2023 Jun; 21(1):418. PubMed ID: 37370092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TUG1 promotes the development of prostate cancer by regulating RLIM.
    Guo BH; Zhao Q; Li HY
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1926-1933. PubMed ID: 30915735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SP1-mediated upregulation of lncRNA SNHG4 functions as a ceRNA for miR-377 to facilitate prostate cancer progression through regulation of ZIC5.
    Wang ZY; Duan Y; Wang P
    J Cell Physiol; 2020 Apr; 235(4):3916-3927. PubMed ID: 31608997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA SNHG1 and RNA binding protein hnRNPL form a complex and coregulate CDH1 to boost the growth and metastasis of prostate cancer.
    Tan X; Chen WB; Lv DJ; Yang TW; Wu KH; Zou LB; Luo J; Zhou XM; Liu GC; Shu FP; Mao XM
    Cell Death Dis; 2021 Feb; 12(2):138. PubMed ID: 33542227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non‑coding RNA AC245100.4 promotes prostate cancer tumorigenesis via the microRNA‑145‑5p/RBBP5 axis.
    Xie H; Zhao J; Wan J; Zhao J; Wang Q; Yang X; Yang W; Lin P; Yu X
    Oncol Rep; 2021 Feb; 45(2):619-629. PubMed ID: 33416179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.